MAK CAPITAL ONE LLC

Position in QURE — uniQure N.V.

CIK 1385702 NEW YORK, NY

Position in QURE

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$7,213,701

New position

Shares Held

441,205

first reported quarter

Ownership

0.700%

of shares outstanding

% of Portfolio

1.22%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

MAK CAPITAL ONE LLC holds $87,613,716 across 5 Biotechnology names. QURE ranks #4 (8.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AUTL	Autolus Therapeutics plc	33,621,487	$46,397,652
2	ANNX	Annexon, Inc.	4,724,043	$26,171,198
3	PLX	Protalix BioTherapeutics, Inc.	3,544,139	$7,690,781
4	QURE	uniQure N.V. This page	441,205	$7,213,701
5	SGMOQ	Sangamo Therapeutics, Inc	561,538	$140,384

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$7,213,701	441,205	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.